Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.32 |
| ▸ | RORC | P51449 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | RORA | P35398 | 1/20 | 0.31 |
| ▸ | RORB | Q92753 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14900782 | 0.92 | KDM4E (0.37) | NPY5RKDM4EATML3MBTL1 | |
| SCHEMBL13443610 | 0.91 | KDM4E (0.36) | KDM4EATML3MBTL1 | |
| SCHEMBL15436081 | 0.91 | KDM4E (0.39) | NPY5RPTGER4KDM4EATML3MBTL1 | |
| SCHEMBL20655042 | 0.91 | KDM4E (0.36) | KDM4EATML3MBTL1 | |
| SCHEMBL19845121 | 0.91 | MEN1 (0.47) | MEN1KMT2ANPY5RBCHEACHE | |
| SCHEMBL13444137 | 0.91 | KDM4E (0.36) | KDM4EATML3MBTL1 | |
| SCHEMBL20277484 | 0.91 | KDM4E (0.36) | KDM4EATML3MBTL1 | |
| SCHEMBL13443604 | 0.91 | KDM4E (0.36) | KDM4EATML3MBTL1 | |
| SCHEMBL20707447 | 0.90 | KDM4E (0.38) | PTGER4KDM4EATML3MBTL1 | |
| SCHEMBL20707434 | 0.90 | KDM4E (0.38) | PTGER4KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180037574-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037574-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | PIEZO1, ETV6, LEF1 | MEN1 435/4885KMT2A 1872/4885NPY5R 3238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.